Digital Alpha and Smart City Capital Mark Successful Launch of Miami Dade Smart Lighting Project
Bright Light Imaging Leverages Alpha Nodus's Gravity Auth, Enhanced by Integration With ADS's MedicsRIS, to Streamline Patient Care
Alpha and Omega Semiconductor Up Over 33%, on Pace for Record Percent Increase -- Data Talk
Promising Potential in Perspective Therapeutics' VMT-alpha-NET Program Amid Market Hesitations
Positive Outlook for Alpha Tau Medical Ltd Amid Clinical and Regulatory Milestones
NEXGEL to Participate in the IAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024
Express News | Korro Bio Has Received Approval From The Australian Bellberry Human Research Ethics Committee And Clearance From The Australian Therapeutic Goods Administration To Initiate A Phase 1/2a Study Of KRRO-110 For Alpha-1 Antitrypsin Deficiency
Arqaam Capital Cuts Alpha Dhabi PT, Maintains at Hold
Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics
Deutsche Bank Invests in German AI Startup Aleph Alpha as Other Backers Grow Stakes
Express News | Alpha Tau Medical Q3 EPS $(0.10) Beats $(0.13) Estimate
CND Life Sciences Receives Grant From The Michael J. Fox Foundation to Study Quantification of Cutaneous Phosphorylated Alpha-Synuclein (P-SYN) in People With Parkinson's Disease
Alpha Tau Price Target Lowered to $5 From $7 at Piper Sandler
Piper Sandler Issues a Buy Rating on Alpha Tau Medical Ltd (DRTS)
Alpha IVF Not Putting All Eggs in One Basket, Eyes Regional Expansion
Alpha Tau Medical Advances in Cancer Treatment Technology
Alpha Tau Medical Targeting First Brain Cancer Treatment in 1H of 2025 >DRTS
Alpha Tau Medical 9-Mos Loss/Shr 32c >DRTS
Alpha Tau Medical 9-Mos Loss $22.3M >DRTS
No Data
No Data